UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Annals of the rheumatic diseases, 2011-04, Vol.70 (4), p.590-596

2011

Volltextzugriff (PDF)

Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials

Annals of the rheumatic diseases, 2010-01, Vol.69 (1), p.226-229

2010

Volltextzugriff (PDF)

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48

Annals of the rheumatic diseases, 2011-07, Vol.70 (7), p.1257-1263

2011

Volltextzugriff (PDF)

Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens

Journal of the European Academy of Dermatology and Venereology, 2012-11, Vol.26 (11), p.1436-1443

2012

Volltextzugriff (PDF)

Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial

Annals of the rheumatic diseases, 2010-01, Vol.69 (1), p.222-225

2010

Volltextzugriff (PDF)

Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study

Annals of the rheumatic diseases, 2006-11, Vol.65 (11), p.1478-1483

2006

Volltextzugriff (PDF)

Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice

Clinical and experimental rheumatology, 2011-01, Vol.29 (1), p.26

2011

Volltextzugriff (PDF)

Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis

Clinical and experimental rheumatology, 2010-03, Vol.28 (2), p.238

2010

Volltextzugriff (PDF)

THU0200 Sustained and Similar Clinical Response to Etanercept After 6 Years of Treatment in Patients with Non-radiographic Axial Spondyloarthritis and Ankylosing Spondylitis: Long-term Results of the Esther Trial

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.267-268

2015

Volltextzugriff (PDF)

Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept

British journal of dermatology (1951), 2009-11, Vol.161 (5), p.1190-1195

2009

Volltextzugriff (PDF)

THU0249 Self-Administered Methotrexate Using a Medi-Jet Auto-Injector Improves Bioavailability Compared with Oral Methotrexate in Adults with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A249-A250

2013

Volltextzugriff (PDF)

Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial

Annals of the rheumatic diseases, 2006-03, Vol.65 (3), p.328-334

2006

Volltextzugriff (PDF)

Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate

Annals of the rheumatic diseases, 2008-10, Vol.67 (10), p.1444-1447

2008

Volltextzugriff (PDF)

Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial

Journal of the European Academy of Dermatology and Venereology, 2011-05, Vol.25 (5), p.559-564

2011

Volltextzugriff (PDF)

The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy

Annals of the rheumatic diseases, 2008-02, Vol.67 (2), p.182-188

2008

Volltextzugriff (PDF)

AB0888 Distribution of active inflammatory lesions on magnetic resonance imaging of the the sacroiliac joints and the spine in patients with early axial spondyloarthritis –results of the esther trial at baseline

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.689-689

2013

Volltextzugriff (PDF)

THU0263 Development of chronic inflammatory changes on whole body magnetic resonance imaging in patients with early axial spondyloarthritis after two years of continuous treatment with etanercept – 2 year data of the esther trial

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.243-244

2013

Volltextzugriff (PDF)

THU0358 Constant Clinical Response in Patients with Early Axial Spondyloarthritis after Continuous Treatment with Etanercept - 4 Year Data of the Esther Trial

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A286-A286

2013

Volltextzugriff (PDF)

THU0273 Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after one year of treatment with etanercept - results of the esther trial

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.247-247

2013

Volltextzugriff (PDF)

FRI0423 Effective prevention of new inflammatory bony lesions on magnetic resonance imaging in patients with early axial spondyloarthritis during treatment with etanercept over 2 years - data of the esther trial

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A517-A518

2013

Volltextzugriff (PDF)

Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial

Annals of the rheumatic diseases, 2008-08, Vol.67 (8), p.1104-1110

2008

Volltextzugriff (PDF)

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

The Lancet (British edition), 2008-08, Vol.372 (9636), p.375-382

2008

Volltextzugriff (PDF)

Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy

Annals of the rheumatic diseases, 2009-07, Vol.68 (7), p.1113-1118

2009

Volltextzugriff (PDF)

Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis

Rheumatology (Oxford, England), 2011-02, Vol.50 (2), p.401-409

2011

Volltextzugriff (PDF)

Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis

Journal of rheumatology, 2003-01, Vol.30 (1), p.36

2003

Volltextzugriff (PDF)

1 – 25 von 285

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(210)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Life Sciences & Biomedicine
(158)
Humans
(152)
Female
(90)
Male
(83)
Biological And Medical Sciences
(78)
Medical Sciences
(65)
Adult
(59)
Middle Aged
(59)
Rheumatology
(33)
Aged
(30)
Adolescent
(23)
Etanercept
(22)
General & Internal Medicine
(22)
Physical Sciences
(22)
Immunoglobulin G - Therapeutic Use
(18)
Receptors, Tumor Necrosis Factor - Therapeutic Use
(18)
Treatment Outcome
(18)
Diseases Of The Osteoarticular System
(17)
Medicine, General & Internal
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48

Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens

Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial

Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study

Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice

Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis

THU0200 Sustained and Similar Clinical Response to Etanercept After 6 Years of Treatment in Patients with Non-radiographic Axial Spondyloarthritis and Ankylosing Spondylitis: Long-term Results of the Esther Trial

Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept

THU0249 Self-Administered Methotrexate Using a Medi-Jet Auto-Injector Improves Bioavailability Compared with Oral Methotrexate in Adults with Rheumatoid Arthritis

Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial

Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate

Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial

The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy

AB0888 Distribution of active inflammatory lesions on magnetic resonance imaging of the the sacroiliac joints and the spine in patients with early axial spondyloarthritis –results of the esther trial at baseline

THU0263 Development of chronic inflammatory changes on whole body magnetic resonance imaging in patients with early axial spondyloarthritis after two years of continuous treatment with etanercept – 2 year data of the esther trial

THU0358 Constant Clinical Response in Patients with Early Axial Spondyloarthritis after Continuous Treatment with Etanercept - 4 Year Data of the Esther Trial

THU0273 Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after one year of treatment with etanercept - results of the esther trial

FRI0423 Effective prevention of new inflammatory bony lesions on magnetic resonance imaging in patients with early axial spondyloarthritis during treatment with etanercept over 2 years - data of the esther trial

Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy

Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis

Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis

Suchergebnisse filtern